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Purpose: Ectopic expression of light-sensitive proteins, such as channelrhodopsin-2, represent a novel approach for
restoring light-detection capabilities to degenerated retina. A noninvasive method that can detect light-mediated activities
of such light-sensitive proteins in the retina in vivo would be important for correlating expression patterns and retinal
function. In this study, we tested the hypothesis that retinal uptake of manganese, measured noninvasively with manganese-
enhanced magnetic resonance imaging (MEMRI), is a biomarker of channelrhodopsin-2-mediated activity in vivo.
Methods: The eyes of 3-month-old rd1/rd1 mice were either untreated (“uninjected,” negative control) or injected
intravitreally with either saline (“saline,” negative control) or adeno-associated virus carrying a fusion construct of
channelopsin-2 (Chop2) and green fluorescent protein (GFP; “Chop2-GFP”). MEMRI examination was performed 2
months later on either dark or continuous bright blue light-exposed mice to assess the distribution and extent of manganese
uptake in the retina and optic nerve. In separate experiments, MEMRI was used to map laminar accumulation of manganese
vertically through the retina. For comparison, Chop2-GFP expression was evaluated in whole mounts and vertical sections
of virus-infected retinas and optic nerve.
Results: In the two control groups (regardless of lighting exposure) and between the control groups and the dark-exposed
virus-treated eyes, retinal and optic nerve uptake of manganese did not differ. In light-exposed virus-treated eyes,
manganese uptake in the retina and optic nerve was significantly greater relative to the other groups. In a retinal cross-
section, manganese accumulation in light-exposed virus-treated eyes was spatially matched with Chop2-GFP expression
in the optic nerve and all remaining retinal layers except the inner nuclear layer.
Conclusions: First-time evidence is presented indicating the usefulness of measuring intraretinal manganese accumulation
as a noninvasive biomarker of channelrhodopsin-2-mediated activity in vivo.
The  death  of  photoreceptors  in  retinal  degenerative
diseases, such as retinitis pigmentosa, results in vision loss
and  blindness.  A  new  strategy  for  treating  such  retinal
degeneration morbidity involves restoring light sensitivity in
the retina by expression of microbial rhodopsins, such as
channelopsin-2 (Chop2), in surviving inner retinal neurons
[1].  Channelrhodopsin-2  (ChR2,  Chop2  with  attached
chromophore) is a directly light-gated nonselective cation
channel [2]. Viral-based gene transfer is a promising tool for
the  delivery  of  transgenes  to  nondividing  mammalian
neurons.  Following  intravitreal  injection  of  recombinant
adeno-associated  virus  serotype  2,  ChR2  expression  is
predominately observed in the retinal ganglion cell and inner
plexiform layers, with additional expression in amacrine and
horizontal cells, as well as in the optic nerve [1,3,4]. ChR2-
mediated  light  sensitivity  in  a  homozygous  rd1  (rd1/rd1)
mouse,  a  mouse  model  of  retinal  degeneration,  has  been
shown in vitro through electrophysiological recording and in
vivo with visual evoked potential recordings [1,5] and visual
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behavioral testing [6,7]. For further refining this treatment
approach, the development of a noninvasive method to detect
the ChR2-mediated activity in the retina in vivo would be
desirable for correlation of expression patterns of ChR2 and
retinal function.
At present, the only noninvasive method available for
measuring  regional  retinal  ion  regulation  in  vivo  is
manganese-enhanced magnetic resonance imaging (MEMRI)
[8–12]. In biologic systems manganese is known to behave
like calcium ions, which are allowed to enter cells through
calcium pathways, such as voltage-gated calcium channels
[13,14]  and  N-methyl-D-aspartate  receptor  [15].  After
systemic  injection  of  a  modest  and  nontoxic  amount  of
MnCl2, manganese is a surrogate biomarker of normal and
diseased retinal function [8–12]. ChR2 channels have been
shown to be permeable for calcium ions [2]. However, the
applicability of using MEMRI to investigate ChR2-induced
activity has not been examined. In this study we test the
hypothesis  that  in  a  retinal  degeneration  model  (rd1/rd1
mouse),  inner  retinal  uptake  of  manganese,  measured
noninvasively  with  MEMRI,  is  a  functional  biomarker  of
ChR2-mediated activity in vivo.
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Animals and viral injection: All of the animal experiments and
procedures were approved by the Institutional Animal Care
and  Use  Committee  at  Wayne  State  University  and  were
performed in accordance with the National Institutes of Health
(NIH) Guide for the Care and Use of Laboratory Animals. The
MEMRI experiments were initially performed using a 4.7T
MRI  system  (Bruker  Avance,  Billerica,  MA)  to  measure
intraretinal signal intensities. When a new 7T system (Bruker
Avance)  became  available,  we  also  performed  additional
experiments  to  take  advantage  of  the  relatively  improved
signal-to-noise  ratio  to  measure  the  spin-lattice  relaxation
time (T1), a parameter whose inverse is more directly related
to retinal manganese level than signal intensity [16].
Three-month-old  rd1/rd1  mice  (purchased  from  the
Jackson  Laboratory,  Bar  Harbor,  ME)  received  either  no
intravitreal  injection  (“uninjected,”  negative  control,  n=3
[dark], n=3 [bright blue light]), an intravitreal injection of
saline vehicle (“saline,” negative control, n=3 [dark], n=3
[bright  blue  light]),  or  an  intravitreal  injection  of  a
recombinant  adeno-associated  virus  serotype  2/2  vector
carrying a fusion construct of channelopsin-2 (Chop2) and
green  fluorescent  protein  (GFP)  under  a  hybrid
cytomegalovirus early enhancer and chicken β-actin (CAG)
promoter  (n=6  [dark],  n=6  [bright  blue  light])  [1].  These
groups were studied on the 4.7T system (see below). A smaller
subset of animals (n=4, bright blue light [one eye Chop2-GFP,
the other uninjected]) were also investigated on the 7T system
(see below).
Viral vectors were packaged and affinity purified by the
Gene Therapy Program at the University of Pennsylvania. The
intravitreal injection procedure has been previously described
[2]. Briefly, a subset of 3-month-old mice (C3H/HeJ or rd1/
rd1) was anesthetized by intraperitoneal injection of a mixture
of ketamine (120 mg/kg) and xylazine (15 mg/kg). Under a
dissecting microscope, a small perforation was made in the
temporal sclera region with a needle. The solution (saline or
viral vector suspension in saline [6×1012 genome copies (GC)/
ml, 1 μl total volume]) was injected into the intravitreal space
through the hole with a Hamilton syringe. In some cases,
injections were performed in both eyes. All virus-injected and
control (uninjected and saline injected) mice were housed in
normal 12-h-cycled laboratory lighting.
High-resolution magnetic resonance imaging experiments: In
all cases MEMRI measurements were performed 2 months
after intravitreal injection. Before the MEMRI measurement,
MnCl2 (Sigma, St. Louis, MO) was injected intraperitoneally
(ip; 66 mg/kg) on the right side of each awake mouse [12];
mice were maintained in either dark or continuous bright blue
light for 4 h. The bright blue light for the first group was
generated  by  high-power  light-emitting  diodes  (LEDs;
LXHL-FR5C; Lumileds Lighting, San Jose, CA) with a peak
wavelength of 455 nm and light intensity of 1.2×1016 photons
cm−2 s−1; these were mounted at the top the animal cage. Before
light exposure, atropine (1%; Bausch and Lomb, Tampa, FL)
was applied to the cornea of all animals to dilate the pupils.
MEMRI examination was performed on a 4.7T Bruker
Avance  system  to  assess  manganese  uptake  horizontally
around the optic nerve head. The 7T Bruker Clinscan was used
to evaluate the vertical distribution of manganese through the
retina. Immediately before each MRI experiment, mice were
anesthetized using urethane (36% solution, ip, 0.083 ml/20 g
animal  weight,  prepared  fresh  daily;  Aldrich,  Milwaukee,
WI).  To  maintain  each  mouse's  core  temperature,  a
recirculating  warm  water  blanket  was  used;  rectal
temperatures were monitored in the magnet using a fiberoptic
thermometer (Luxtron, Santa Clara, CA) [17]. In most mice,
left and right eyes were separately examined using a 1.0-cm
diameter coil.
On the 4.7T, we used an adiabatic pulse sequence [18] to
collect a single transverse slice that was positioned in the
middle of the lens and middle of the optic nerve (i.e., through
the center of the eye). High-resolution images were acquired
using an adiabatic spin-echo imaging sequence (repetition
time  [TR]  350  s,  echo  time  [TE]  16.7  ms,  number  of
acquisitions [NA] 16, matrix size 256×512, slice thickness
620 μm, field of view 12×12 mm2, 27 min/image) [18]. These
conditions provided 23.4 μm intraretinal resolution near the
optic nerve head. On the 7T, a body coil transmission/surface
coil  reception  arrangement  was  used.  After  positioning  a
medial  slice  (as  above),  partial  saturation  T1  data  were
acquired  (TE  13,  matrix  size  160×320,  slice  thickness
600 μm, field of view 7×7 mm2). At each TR, several single
images (in parentheses) were acquired in the following order:
TR 0.15 s (6), 3.5 s (1), 1.0 s (2), 1.9 s (1), 0.35 s (4), 2.7 s (1),
0.25 s (5), 0.5 s (3). The virus-injected eye was scanned first
in two of the four animals studied on the 7T system.
Magnetic resonance imaging data analysis:
4.7T data—Retinal and optic nerve (in a small region-
of-interest  immediately  posterior  to  the  retina)  signal
intensities were normalized to the signal intensity of the same
extraocular muscle in each animal to minimize differences in
systemic manganese handling. Note that the data collection
was  optimized  for  retinal  acquisition  and  not  optic  nerve
acquisition.  In  some  cases,  an  oblique  slice  prevented
observing and thus prevented analyzing the optic nerve so that
the  number  of  eyes  used  in  the  optic  nerve  analysis  was
somewhat  smaller  than  that  for  the  retinal  analysis.  The
muscle intensities were measured from a fixed-size region-of-
interest drawn in the anterior-most aspect of the inferior rectus
muscle. For visualization and comparison purposes, in-house
written software was used to map the in situ image into a linear
representation for each retina. First, the vitreoretinal border
and  optic  nerve  were  manually  defined.  A  high-order
polynomial was fit to the vitreoretinal border. Retinal data was
oversampled along lines perpendicular to the polynomial, and
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head as its origin [19]. Within each group, linearized retinas
were  averaged  into  a  composite  image.  For  quantitative
analysis, signal intensities were analyzed using the program
NIH IMAGE and derived macros. Vertically, retinal signal
intensity data were extracted at 3 pixels posterior to the clearly
defined vitreoretinal division (approximately at the level of
the inner nuclear layer [INL]). This location was chosen based
on our previous work in nondegenerated retinas, the inner
retina of the rd1/rd1 mice in this study which has normal
thickness, and results from 7T vertical mapping. Horizontally,
pixels were extracted between 0.4 and 1 mm on either side of
the optic nerve (i.e., superior and inferior retina) and were
analyzed.  Intraretinal  signal  intensity  was  analyzed  using
IMAGE  (a  public  domain  image  processing  and  analysis
program) and derived macros. We controlled for changes in
receiver gain differences between animals by normalizing the
signal intensity of a fixed region of noise in each rat to a fixed
value. Other tissues within the sensitive volume of the coil
demonstrated  enhancement  after  manganese  injection  and
thus were considered inadequate as internal references. Inner
and outer signal intensity data were extracted and analyzed
[12].  Initial  efforts  to  compare  the  4.7T  data  of  vertical
manganese  distribution  to  the  distribution  of  Chop2-GFP
expression ex vivo was limited by an apparent homogenous
signal  from  the  entire  retina  (data  not  shown).  Since  the
combination of higher magnetic field and T1 mapping can
provide spatial clarity over a signal intensity analysis [20], T1
studies were performed on the 7T system using a small subset
of conditions in a paired-eye design (see above).
7T data—Single images acquired with the same TR were
registered (rigid body), then averaged. These averaged images
were then registered across TRs, and retinas were linearized
as before [19]. Using the linearized data, 1/T1 maps were
generated by fitting a three-parameter T1 equation (y=a +
b[exp(-cTR)], where a, b, and c are fitted parameters) on a
pixel-by-pixel basis using R (v.2.9.0, R Development Core
Team 2009) scripts developed in-house and the minpack.lm
package (v.1.1.1, Timur V. Elzhov and Katharine M. Mullen
minpack.lm:  R  interface  to  the  Levenberg-Marquardt
nonlinear  least-squares  algorithm  found  in  MINPACK.  R
package version 1.1–1.). The reciprocal (1/T1) maps directly
reflect manganese levels [16]. Between eyes, linearized maps
were aligned using an automated x–y registration (align slices
in  stack  plugin  of  ImageJ),  and  average  virus  injected  or
noninjected parameter maps were derived.
Analysis of channelopsin-2 expression:  The expression of
Chop2-GFP in the retina was studied in whole mounts (i.e., a
horizontal analysis) and in vertical sections following 4 h of
bright  blue  light  exposure.  Immediately  after  MRI
examination anesthetized mice were decapitated, superior/
inferior eye orientation externally marked, and the eyes were
enucleated. The retinas were fixed in the eyecups with 4%
paraformaldehyde in 0.1 M phosphate buffer (PB) for 20 min.
For the cryostat sections the retinas were cryoprotected with
all three solutions starting with 10%, then 20%, and finally
30% weight/volume in PB, which called sucrose gradient and
sections were cut at 20 μm. For the whole mounts, the retina
was dissected free in PB solution, flat mounted on slides, and
coverslipped.
GFP fluorescence, without antibody enhancement, was
sufficient to visualize most of the GFP expressing cells in
whole mounts and retinal sections.
For double labeling, retinal sections were blocked for 1
h  in  a  PB  solution  that  contained  5%  Chemiblocker
(membrane-blocking agent; Chemicon, Temecula, CA), 0.5%
Triton  X-100,  and  0.05%  sodium  azide.  The  primary
antibodies  were  diluted  in  the  same  solution  and  applied
overnight followed by secondary antibodies for 2 h. All steps
were performed at room temperature. The primary antibodies
were  rabbit  anti-GFP  antibody  conjugated  to  Alexa488
(1:2,000; Molecular Probes, Eugene, OR) and mouse anti-
calbindin  antibody  (1:5,000;  Sigma,  Saint  Louis,  MO).
Secondary antibodies for calbindin were donkey antimouse
Alexa555 (1:600; Molecular Probes).
All images were acquired using a Zeiss Axioplan 2 (Zeiss,
Oberkochen,  Germany)  microscope  with  the  Apotome
oscillating grating to reduce out-of-focus stray light. Z-stack
images were captured using a Zeiss Apotome microscope with
a  fixed  exposure  time.  Image  projections  were  made  by
averaging individual z-stacks of optical sections into a single
image,  unless  otherwise  indicated.  The  brightness  and
contrast were maximized for each average image using Adobe
Photoshop CS4 (Adobe systems incorporated, New York,
NY).  For  comparison,  differential  interference  contrast
images were also collected.
Statistical analysis: Comparisons of MEMRI retinal signal
intensities within and between groups were performed using
a  generalized  estimating  equation  approach  [12,21].  A
generalized  estimating  equation  performs  a  general  linear
regression analysis using all of the pixels in each subject and
accounts for the within-subject correlation between adjacent
pixels.  In  all  cases,  p<0.05  was  considered  statistically
significant. Data are presented as mean±standard error of the
mean (SEM) unless otherwise noted.
RESULTS
Horizontal  analysis:  After  MEMRI  examination,  retinal
whole mounts were prepared to evaluate the ganglion cell
layer expression of Chop2-GFP of all virus-injected eyes. As
expected  all  eyes  showed  robust  expression  of  GFP  in
ganglion cell somas, dendrites, and axons, with regions of
high expression levels close to the optic nerve head (Figure
1A).  In  this  restricted  region  GFP  fluorescence  appeared
symmetrically and evenly distributed about the optic nerve
(Figure 1B-H; white rectangular) in both dark-adapted (Figure
1B-D) and light-exposed (Figure 1E-H) retinas.
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were analyzed from the MEMRI data (±0.4–1 mm from the
optic nerve head in superior–inferior directions; 620 μm slice
thickness). Signal intensities of light-exposed, virus-treated
eyes  were  not  different  (p>0.05)  between  superior  (mean
±SEM  113.4±2.1  arbitrary  units  [a.u.])  and  inferior
(116.4±2.2  a.u.)  retina;  these  regions  were  combined  for
further  analysis.  Horizontal  signal  intensities  were  not
different  (p>0.05)  between  the  two  control  groups  (i.e.,
uninjected and saline-injected groups), regardless of lighting
condition (Figure 2); these data were pooled for additional
comparison. Also, no difference (p>0.05) was found between
the combined control signal intensity and that in dark-exposed
virus-treated eyes (Figure 2). Signal intensities from light-
exposed  virus-treated  eyes  were  significantly  different
(p<0.05) compared to each of the other groups (Figure 2).
In  the  retinal  optic  nerve,  no  differences  (p>0.05)  in
retinal  manganese  accumulation  were  found  between  the
noninjected and saline-injected eyes regardless of lighting
condition  (Figure  3),  and  the  data  were  combined.  The
Figure  2.  Horizontal  analysis  of  the  retina  in  light  and  dark
conditions. Retinal signal intensities were measured in combined
control groups (i.e., from noninjected and saline injected animals;
(A) and in virus-injected mice (B). The numbers of animals used to
generate these data are listed above each group. Error bars represent
the standard error of the mean. *, p<0.05 was considered significant
for the between-group comparison.
Figure 1. Whole-mount retinas injected with channelopsin-2 viral constructs. A: A representative whole-mount retina with channelopsin-2
(Chop2-GFP) expression is shown at low resolution. A white rectangle frames the area around the optic nerve head that was analyzed in the
manganese-enhanced magnetic resonance imaging (MEMRI) study; this area is shown magnified in E. B-H: Expression of Chop2-GFP was
studied in montaged and magnified images of the retinas of dark-exposed mice (B-D) and light-exposed mice (E-H). Scale bars are 2 mm in
A and 0.5 mm in B-H. Abbreviations are as follows: S represents superior, I represents inferior, N represents nasal, T represents temporal.
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to that of dark-exposed virus-treated eyes (50.2±5.7 a.u., n=6).
For comparison, light-exposed virus-treated eyes had a greater
(p<0.05) optic nerve signal relative to that of the combined
control groups as well as that of the combined control groups
and dark-exposed Chop2-GFP (Figure 3).
Vertical analysis: After MEMRI experiments and subsequent
inspection  in  whole  mounts,  the  Chop2-GFP-expressing
retinas  were  further  investigated  in  cryostat  sections.  The
Chop2-GFP fluorescence was predominantly observed in the
inner plexiform layer and in the ganglion cell layer (Figure
4A). In the INL, some AII amacrine cells were also labeled
[3]. GFP-positive cells at the outer border of the INL are
horizontal cells (based on double labeling with the antibody
against  calbindin,  Figure  5).  No  glial  cells  with  GFP
fluorescence were detected. In the same retina vertical section,
differential interference contrast images are consistent with
the absence of photoreceptors (Figure 4B).
For MEMRI we collected the signals in the areas between
±0.4–1 mm on superior and inferior sides of the optic nerve.
The signal was averaged over 600 μm retinal thickness (Figure
4C,D) and thus represents more partial volume averaging than
that  shown  in  Figure  4A,B.  Relative  to  noninjected  eyes
(Figure 4C), light-exposed virus-infected eyes (Figure 4D)
accumulated more (p<0.05) manganese in the retinal ganglion
cells, inner plexiform, and inner nuclear layers (INLs).
DISCUSSION
In this study the major findings are that rd1/rd1 mice with
Chop2-GFP expression and exposure to bright blue light had
1) a horizontal distribution of manganese and Chop2-GFP
expression  that  were  symmetric  about  the  optic  nerve,  2)
retinal and optic nerve accumulation of manganese that was
greater than that measured in a series of control conditions,
Figure 3. Optic nerve analysis in light
and  dark  conditions.  A:  Region-of-
interest on optic nerve of light-exposed
ChR2-infected eye is shown in the white
box. Optic nerve signal intensities were
measured  in  the  combined  control
groups  (i.e.,  from  noninjected  and
saline-injected animals; (B) and in the
virus-injected mice (C). The numbers of
animals used to generate these data are
listed  above  each  group.  Error  bars
represent the standard error of the mean.
*, p<0.05 was considered significant for
the comparison between light-exposed
Chop2-GFP eyes and combined control
groups as well as that of the combined
control  groups  and  dark-exposed
Chop2-GFP .
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1063and 3) vertical loci of manganese accumulation and Chop2-
GFP expression that were largely similar, except possibly in
the INL (vide infra). These findings demonstrate for the first
time the feasibility of using MEMRI to measure regional light
responses in Chop2-GFP-expressing retinas in vivo.
The  rd1/rd1  mouse  [22,23]  is  a  widely  used
photoreceptor  degeneration  model  that  undergoes  rapid
retinal degeneration due to a defect in the β-subunit of a rod-
specific  cyclic  guanosine  monophosphate  (cGMP)-
phosphodiesterase and lacks the entire photoreceptor layer in
adulthood  [22].  The  rd  mutation  initially  affects  rod
photoreceptors, followed by a slower degradation of cones.
By 4 months of age only approximately 1.3% of cones are left
in the central retina [24,25]. In this study, the observed light-
and dark-induced changes in the surviving retina measured (at
the age of 4–5 months old) could be manifested by remaining
cones  [24,25],  endogenous  melanopsin  [26],  and/or
exogenously  introduced  ChR2  [1].  However,  it  seems
unlikely that melanopsin or the remaining cones are playing
a  role  in  the  present  study.  In  the  two  non-virus-injected
control groups, no change in manganese uptake between light
and dark conditions were found. Also, unlike the newborn
retina,  in  the  adult  retina  of  wild-type  and  rd1/rd1  mice,
melanopsin is normally present in only a relatively small
number  of  specialized  ganglion  cells  [27,28].  With  these
considerations and given the large ectopic expression of ChR2
in this study (Figure 1), it is reasonable to conclude that ChR2
expression dominates the observed light/dark effect.
Previous  evidence  indicated  that  the  intensity  of  the
bright blue light used herein is sufficient to activate ChR2 in
the retina in vivo [3,6]. As shown in Figure 2, such blue light
exposure after ChR2 treatment also significantly increased
manganese uptake. To the best of our knowledge, it is not yet
known if manganese ions directly permeate the ChR2 channel.
However, Mn2+ can act as a Ca2+ surrogate, and calcium ions
are  reported  to  permeate  the  ChR2  channel  [2,29].  An
alternative and not mutually exclusive possibility is that a
light-induced  opening  of  the  ChR2  channel  causes
depolarization of the cell membrane, which activated other
membrane  conductances,  including  L-type  voltage-gated
calcium channels. L-type voltage-gated calcium channels are
expressed throughout the rodent retina [30]. Since manganese
readily  permeates  L-type  channels,  we  speculate  that  this
indirect  ChR2-mediated  route  would  be,  at  least  in  part,
involved in the manganese uptake [11,29].
In light-exposed eyes, reasonable agreement was found
between retinal and optic nerve manganese accumulation and
Chop2-GFP expression and in the inner half of the surviving
retina  (i.e.,  the  ganglion  cell  and  inner  plexiform  layers).
Although focal detection of Chop2-GFP-positive amacrine
and horizontal cells was found in the INL, the 1/T1 maps
suggested a somewhat greater involvement of the entire outer
half of the remaining retina—corresponding to the INL—of
the light-exposed virus-injected eyes (Figure 4D).
In the light-exposed virus-treated eyes, depolarization of
the  neurons  in  the  INL  with  subsequent  manganese
accumulation might be possible. For example, the Chop2-
GFP expressing amacrine cells (Figure 4A), together along
with their downstream ON cone bipolar cells could depolarize
during light illumination [31]. In addition, with light exposure
horizontal  cells  expressing  Chop2-GFP  (Figure  4A)  may
depolarize,  releasing  gamma-aminobutyric  acid  (GABA).
Rod bipolar cells in rd1/rd1 mice retain functional dendritic
GABA receptors [32]. In wild-type retinas GABA leads to
depolarization of ON bipolar cells [33]. Assuming that the
chloride  gradient  in  bipolar  cells  of  rd1/rd1  mice  is
comparable  to  that  of  wild-type  mice,  ChR2-mediated
depolarization  of  horizontal  cells  could  also  lead  to
depolarization  of  ON  bipolar  cells.  These  considerations
support the idea that, in response to light, ChR2-expressing,
Figure 4. Vertical analysis of the retina. A: Numerous green fluorescent protein (GFP)-positive ganglion, amacrine, and horizontal cells can
be seen in the cryostat section of a retina after a light-exposed magnetic resonance imaging experiment. B: Nomarski image of the same region
shown in (A) reveals the absence of photoreceptors. Abbreviations are as follows: INL represents inner nuclear layer; IPL represents inner
plexiform layer; GCL represents ganglion cell layer. The scale bar is equal to 25 μm in A and B. C-D: Pseudocolor linearized average 1/T1
maps of the central retina from uninjected (C) and virus injected (D) eyes, scaled vertically to approximately match the boundaries of (A) and
(B). The pseudocolor scale was blue to green to yellow to red, which represents lowest (0.56 s−1) to highest (2.25 s−1) 1/T1 values. 1/T1 is
directly proportional to manganese concentration [16]. The vertical scale bar is equal to 130 μm, and the horizontal scale bar is 0.6 mm and
applies to C and D.
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1064amacrine, and horizontal cells can lead to depolarization of
ON bipolar cells, with the increased possibility of greater
manganese  entry  and  accumulation.  While  the  present
resolution  of  the  current  MEMRI  data  (23.4  μm)  was
sufficient in 1/T1 maps of uninjected eyes to separate the inner
from  the  outer  half  of  the  surviving  retina,  it  may  be
inadequate for finer discrimination of histological sublamina.
Also,  while  image  registration  and  linearization  were
Figure 5. Double labeling of a retina after light-exposed magnetic
resonance imaging experiment. Numerous green fluorescent protein
(GFP)-positive cells (arrows, A) were immunolabelled for calbindin
(B), a marker of horizontal cells. Merge image is shown in C. These
data do not suggest that there were substantial numbers of infected
remodeled  cones  (which  would  not  be  stained  for  calbindin).
Abbreviations are as follows: INL represents inner nuclear layer; IPL
represents inner plexiform layer; GCL represents ganglion cell layer.
The scale bar is equal to 25 μm.
reasonably accurate, some subtle reductions in the effective
resolution of retinal structure are likely. The distance between
AII amacrine cells in the inner portion of the INL and the
horizontal  cells  in  the  outer  portion  of  the  INL  is  about
20 μm. For these reasons, in the light-exposed virus-injected
retinal 1/T1 map (Figure 4D), the absence of a “gap” in the
space corresponding to mid-INL should not be construed as
definitive evidence that bipolar cells show light-dependent
depolarization in ChR2-expressing retinas. More work, with
higher spatial resolution, is needed to test the reasonableness
of these ideas.
In  summary,  first-time  evidence  is  presented  that
demonstrates  the  sensitivity  of  MEMRI  to  regional  light
responses in Chop2-GFP-expressing retinas. More work is
now  needed  to  analytically  evaluate  how  the  spatial
distribution and extent of retinal manganese uptake are linked,
for example, with light exposure frequency and intensity.
Nonetheless, these data raise the possibility that MEMRI will
be useful in analytically evaluating the activity of ChR2, or
its derivatives, or other microbial rhodopsins in the retina
[34,35].  Thus,  MEMRI  is  expected  to  facilitate  the
development and evaluation of the ChR2-based gene therapy
for treating retinal degenerative diseases.
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